LLY - Eli Lilly and • Dividends
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
See below the complete and updated table with all dividends paid and declared history, etc
DY 0,5%
DY 0,5%
1/10
The latest dividend from LLY was $1.73 per share (ex-dividend 8/14/2026). The dividend yield over the last 12 months is 0,5%. Over the last 12 months there were 4 distributions, totalling $6.69 per share.